SCHEMBL8749598

SCHEMBL8749598

CC1(C)[CH]CC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11173356 0.66
SCHEMBL19579756 0.64
SCHEMBL10581089 0.63
SCHEMBL9098607 0.61
SCHEMBL989793 0.61
SCHEMBL453523 0.55
SCHEMBL668276 0.52
SCHEMBL7891037 0.52
SCHEMBL2380300 0.52
SCHEMBL2146945 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4045095-B1 IRON (III) COMPLEXES WITH NOVEL CONTRAST PROPERTIES FOR MAGNETIC RESONANCE IMAGING UNIV BERLIN CHARITE (DE) 2023-08-02 EP disclosed
EP-4045095-A1 IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR MAGNETIC RESONANCE IMAGING Charité - Universitätsmedizin Berlin (DE) 2022-08-24 EP disclosed
WO-2021074368-A1 IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR MAGNETIC RESONANCE IMAGING CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN (DE) 2021-04-22 WO disclosed
EP-3808381-A1 IRON (III) COMPLEXES WITH NOVEL CONTRAST PROPERTIES FOR MAGNETIC RESONANCE IMAGING Charité - Universitätsmedizin Berlin (DE) 2021-04-21 EP disclosed
EP-3383839-B1 PROCESS FOR THE PREPARATION OF N,N´-UNSUBSTITUTED CARBOXAMIDINES ALZCHEM TROSTBERG GMBH (DE) 2020-05-06 EP disclosed
EP-3118238-B1 LIQUID HARDENERS FOR CURING EPOXY RESINS (I) ALZCHEM TROSTBERG GMBH (DE) 2020-03-18 EP disclosed
EP-3536725-A1 BIOCIDAL COATING MATERIAL AND METHOD OF MANUFACTURING THE SAME El Kudsi, Karim (DE) 2019-09-11 EP disclosed
EP-3383839-A2 PROCESS FOR THE PREPARATION OF N,N´-UNSUBSTITUTED CARBOXAMIDINES AlzChem Trostberg GmbH (DE) 2018-10-10 EP disclosed
WO-2017093495-A2 PROCESS FOR THE PREPARATION OF N,N´-UNSUBSTITUTED CARBOXAMIDINES ALZCHEM AG (DE) 2017-06-08 WO disclosed
EP-3118238-A1 LIQUID HARDENERS FOR CURING EPOXY RESINS (I) AlzChem AG (DE) 2017-01-18 EP disclosed
WO-1992017185-A1 TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES UNIVERSITY OF FLORIDA (US) 1992-10-15 WO disclosed
US-5135926-A Treatment of prevention of cardiovascular disorders; treatment of glaucoma IVAX International GmbH (CH) 1992-08-04 US disclosed
WO-1992000988-A1 TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES BODOR NICHOLAS S (US) 1992-01-23 WO disclosed
US-5079366-A To derivatize pharmaceutical peptides for transport across the blood/brain barrier UNIVERSITY OF FLORIDA (US) 1992-01-07 US disclosed
EP-0174956-B1 SOFT $g(b)-ADRENERGIC BLOCKING AGENTS BODOR, Nicholas S. (US) 1990-08-16 EP disclosed
US-4888427-A DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX SYSTEM UNIVERSITY OF FLORIDA (US) 1989-12-19 US disclosed
US-4829086-A Soft β-adrenergic blocking agents IVAX International GmbH (CH) 1989-05-09 US disclosed
EP-0293071-A1 Redox amino acids and peptides containing them UNIVERSITY OF FLORIDA (US) 1988-11-30 EP disclosed
EP-0174956-A1 SOFT -g(b)-ADRENERGIC BLOCKING AGENTS. BODOR NICHOLAS S 1986-03-26 EP disclosed
WO-1985004168-A1 SOFT beta-ADRENERGIC BLOCKING AGENTS BODOR NICHOLAS S 1985-09-26 WO disclosed